{"id":"NCT02139228","sponsor":"Novartis Vaccines","briefTitle":"Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children","officialTitle":"A Phase IIIb, Controlled, Open Label, Single-Center, Persistency, Extension Study in Chinese Children After a 2+1 Dose Series of Either CRM197-Conjugate Haemophilus Influenzae Type b Vaccine or Tetanus Toxoid-Conjugate Haemophilus Influenzae Type b Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11","primaryCompletion":"2014-12","completion":"2015-01","firstPosted":"2014-05-15","resultsPosted":"2015-11-09","lastUpdate":"2015-11-09"},"enrollment":426,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b"],"interventions":[{"type":"BIOLOGICAL","name":"Hib-CRM197","otherNames":[]},{"type":"BIOLOGICAL","name":"Hib-TT","otherNames":[]}],"arms":[{"label":"Hib CRM197","type":"EXPERIMENTAL"},{"label":"Hib TT","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluate the persistency of immune response against Haemophilus influenzae type b by assessing anti-PRP antibody levels in children vaccinated with either Hib-CRM197 or Hib-TT booster vaccine approximately 4 years before.","primaryOutcome":{"measure":"Geometric Mean Anti-PRP (Polyribosyl Ribitol Phosphate) Concentrations at Day 1 (4 Years Post Booster Dose Administered in Study V37_07E1)","timeFrame":"At Day 1 (4 years post booster dose administered in study V37_07E1)","effectByArm":[{"arm":"Hib CRM197","deltaMin":2.66,"sd":null},{"arm":"Hib TT","deltaMin":5.05,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}